Stock Research: Medios

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Medios

XTRA:ILM1 DE000A1MMCC8
79
  • Value
    86
  • Growth
    69
  • Safety
    Safety
    68
  • Combined
    98
  • Sentiment
    23
  • 360° View
    360° View
    79
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Medios AG is a Germany-based company providing solutions in the pharma industry, covering pharmaceutical supply and manufacture of patient-specific therapies. It operates in pharmaceutical wholesale with finished specialty pharma medications (oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia) and pharmaceutical manufacturing of patient-specific preparations (Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products). The company operates in Germany. In the last fiscal year, the company had a market cap of $363 million, profits of $157 million, revenue of $1950 million, and 1003 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 79 (better than 79% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Medios are very positive. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators above average for Medios. The consolidated Value Rank has an attractive rank of 68, which means that the share price of Medios is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 68% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 69, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. The company is also safely financed with a Safety Rank of 86. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of only 23. Professional investors are more confident in 77% other stocks. ...read more

more
Index
CDAX
SDAX
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
68 78 66 47
Growth
69 86 65 97
Safety
Safety
86 96 100 96
Sentiment
23 42 78 81
360° View
360° View
79 93 96 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
87 93 97 95
Opinions Change
18 40 50 50
Pro Holdings
n/a 14 62 69
Market Pulse
38 35 41 26
Sentiment
23 42 78 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
68 78 66 47
Growth
69 86 65 97
Safety Safety
86 96 100 96
Combined
98 98 96 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
87 85 72 50
Price vs. Earnings (P/E)
100 93 89 85
Price vs. Book (P/B)
92 95 90 72
Dividend Yield
1 1 1 1
Value
68 78 66 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
14 73 32 94
Profit Growth
90 65 88 80
Capital Growth
100 95 64 100
Stock Returns
27 46 35 37
Growth
69 86 65 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
67 90 94 84
Refinancing
96 34 95 83
Liquidity
33 93 88 74
Safety Safety
86 96 100 96

Similar Stocks

Discover high‑ranked alternatives to Medios and broaden your portfolio horizons.

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Continental

XTRA:CON
Country: Germany
Industry: Auto Parts & Equipment
Size: X-Large
Full Stock Analysis

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.